Offerings - Offering: 1 shares in Thousands	Aug. 05, 2026 USD ($) shares
Offering:
Fee Previously Paid	false
Other Rule	true
Security Type	Equity
Security Class Title	Common stock, par value $0.10 per share
Amount Registered \| shares	1,250
Proposed Maximum Offering Price per Unit	11.66
Maximum Aggregate Offering Price	$ 14,575,000
Fee Rate	0.01381%
Amount of Registration Fee	$ 2,012.81
Offering Note	(1) Represents 1,250,000 shares of the Company’s common stock, par value $0.10 per share (“Common Stock”), to be issued under the Orthofix Medical Inc. Second Amended and Restated Stock Purchase Plan, as amended (the “SPP”) (representing the increased number of shares of Common Stock authorized by the amendment to the SPP that was approved by the Company’s shareholders on June 10, 2026). The SPP authorizes the issuance of up to 6,100,000 shares of Common Stock (including the 1,250,000 shares of Common Stock registered hereby). Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also registers any additional securities to be offered or issued in connection with stock splits, stock dividends, recapitalizations, or similar transactions. (2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act. The offering price per share and aggregate offering price are based upon the average of the high and low prices per share of common stock of the Registrant as reported on the Nasdaq Global Select Market on July 31, 2026, which was $11.66 per share.

Offerings - Offering: 1
shares in Thousands

Aug. 05, 2026

USD ($)

Offering:

false

true

Equity

Common stock, par value $0.10 per share

Amount Registered | shares

1,250

Proposed Maximum Offering Price per Unit

11.66

Maximum Aggregate Offering Price

$ 14,575,000

Fee Rate

0.01381%

Amount of Registration Fee

$ 2,012.81

Offering Note

(1)

Represents 1,250,000 shares of the Company’s common stock, par value $0.10 per share (“Common Stock”), to be issued under the Orthofix Medical Inc. Second Amended and Restated Stock Purchase Plan, as amended (the “SPP”) (representing the increased number of shares of Common Stock authorized by the amendment to the SPP that was approved by the Company’s shareholders on June 10, 2026). The SPP authorizes the issuance of up to 6,100,000 shares of Common Stock (including the 1,250,000 shares of Common Stock registered hereby). Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also registers any additional securities to be offered or issued in connection with stock splits, stock dividends, recapitalizations, or similar transactions.

(2)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act. The offering price per share and aggregate offering price are based upon the average of the high and low prices per share of common stock of the Registrant as reported on the Nasdaq Global Select Market on July 31, 2026, which was $11.66 per share.